<NAME start="1" local_name_id="1" end="13" id="728300_2" all_names="SLIP OPINION" >Slip Opinion</NAME>

<NAME start="28" local_name_id="2" end="40" id="728300_3" all_names="OCTOBER TERM" >OCTOBER TERM</NAME>

<DATE start="42" end="46" id="728300_1" >2011</DATE>

<NAME start="127" local_name_id="3" end="135" id="728300_4" all_names="SYLLABUS" >Syllabus</NAME>

<NAME start="146" local_name_id="4" end="150" id="728300_5" all_names="NOTE" >NOTE</NAME>

<CITATION party2="NOVO NORDISK A/S ET AL" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD.,        ET AL." citation_global_level_id="111066.001" party2_short="S" line="4" id="728300_7" end="709" no_current_file="True" entry_type="party_key" lookup_key="laboratoriess#1" id1="Dummy_File_47216" start="628" party1_short="LABORATORIES" citation_local_level_id="0" >CARACO PHARMACEUTICAL LABORATORIES, LTD., ET AL. v. NOVO NORDISK A/S ET AL</CITATION>

<NAME end="683" start="628" party1_of="728300_7" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_8" >CARACO PHARMACEUTICAL LABORATORIES, LTD., ET AL.</NAME>

<ORGANIZATION start="628" end="667" id="728300_13" >CARACO PHARMACEUTICAL LABORATORIES, LTD</ORGANIZATION>

<NAME end="709" start="687" all_names="NOVO NORDISK A/S" party2_of="728300_7" local_name_id="6" id="728300_9" >NOVO NORDISK A/S ET AL</NAME>

<ORGANIZATION start="712" end="800" id="728300_14" >CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT</ORGANIZATION>

<DOCKET entry_type="docket" line="4" end="816" id="728300_6" start="810" >10–844</DOCKET>

<DATE start="830" end="846" id="728300_10" >December 5, 2011</DATE>

<DATE start="855" end="869" id="728300_11" >April 17, 2012</DATE>

<CITATION end="878" line="4" id="728300_12" citation_global_level_id="111067.001" name="The Food" no_current_file="True" entry_type="case_key" lookup_key="the food#1" id1="Dummy_File_47217" start="870" citation_local_level_id="1" >The Food</CITATION>

<NAME start="2174" local_name_id="7" end="2185" id="728300_21" all_names="ORANGE BOOK" >Orange Book</NAME>

<LEGAL_ROLE start="2190" end="2204" id="728300_22" >ANDA applicant</LEGAL_ROLE>

<NAME start="2258" local_name_id="8" end="2261" id="728300_23" all_names="FDA" >FDA</NAME>

<NAME start="2596" local_name_id="9" end="2603" id="728300_24" all_names="U S C	NOVO NORDISK A/S OPINION OF THE COURT SEE 21 U S C" >U. S. C</NAME>

<NAME start="2712" local_name_id="10" end="2715" id="728300_25" all_names="CFR" >CFR</NAME>

<CITATION party2="NOVO NORDISK A/S" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111066.001" party2_short="S" line="5" id="728300_18" end="2805" no_current_file="True" entry_type="party_key" lookup_key="laboratoriess#1" id1="Dummy_File_47216" start="2725" party1_short="LABORATORIES" citation_local_level_id="2" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S</CITATION>

<NAME end="2765" start="2725" party1_of="728300_18" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_19" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<ORGANIZATION start="2725" end="2764" id="728300_26" >CARACO PHARMACEUTICAL LABORATORIES, LTD</ORGANIZATION>

<NAME end="2805" start="2789" all_names="NOVO NORDISK A/S" party2_of="728300_18" local_name_id="6" id="728300_20" >NOVO NORDISK A/S</NAME>

<DATE start="3416" end="3420" id="728300_29" >2002</DATE>

<ORGANIZATION start="3426" end="3450" id="728300_30" >Federal Trade Commission</ORGANIZATION>

<NAME start="3452" local_name_id="11" end="3455" id="728300_31" all_names="FTC" >FTC</NAME>

<NAME start="3568" local_name_id="8" end="3571" id="728300_32" all_names="FDA" >FDA</NAME>

<NAME start="3650" local_name_id="12" end="3658" id="728300_33" all_names="CONGRESS" >Congress</NAME>

<NAME start="3996" local_name_id="9" end="4003" id="728300_34" all_names="U S C	NOVO NORDISK A/S OPINION OF THE COURT SEE 21 U S C" >U. S. C</NAME>

<NAME start="4108" local_name_id="9" end="4115" id="728300_35" all_names="U S C	NOVO NORDISK A/S OPINION OF THE COURT SEE 21 U S C" >U. S. C</NAME>

<LEGAL_ROLE start="4214" end="4225" plural="True" id="728300_72" >Respondents</LEGAL_ROLE>

<NAME start="4240" local_name_id="13" end="4244" id="728300_73" all_names="NOVO" >Novo</NAME>

<NAME start="4325" local_name_id="8" end="4328" id="728300_74" all_names="FDA" >FDA</NAME>

<NAME start="4374" local_name_id="13" end="4378" id="728300_75" all_names="NOVO" >Novo</NAME>

<LEGAL_ROLE start="4423" end="4434" plural="True" id="728300_76" >Petitioners</LEGAL_ROLE>

<NAME start="4449" local_name_id="14" end="4455" id="728300_77" all_names="CARACO" >Caraco</NAME>

<NAME start="4549" local_name_id="14" end="4555" id="728300_78" all_names="CARACO" >Caraco</NAME>

<NAME start="4588" local_name_id="15" end="4590" id="728300_79" all_names="IV" >IV</NAME>

<NAME start="4657" local_name_id="13" end="4661" id="728300_80" all_names="NOVO" >Novo</NAME>

<NAME start="4676" local_name_id="14" end="4682" id="728300_81" all_names="CARACO" >Caraco</NAME>

<NAME start="4760" local_name_id="13" end="4764" id="728300_82" all_names="NOVO" >Novo</NAME>

<NAME start="4804" local_name_id="8" end="4807" id="728300_83" all_names="FDA" >FDA</NAME>

<NAME start="4822" local_name_id="14" end="4828" id="728300_84" all_names="CARACO" >Caraco</NAME>

<NAME start="4831" local_name_id="16" end="4835" id="728300_85" all_names="ANDA" >ANDA</NAME>

<NAME start="4837" local_name_id="13" end="4841" id="728300_86" all_names="NOVO" >Novo</NAME>

<NAME start="4965" local_name_id="14" end="4971" id="728300_87" all_names="CARACO" >Caraco</NAME>

<NAME start="5013" local_name_id="13" end="5017" id="728300_88" all_names="NOVO" >Novo</NAME>

<NAME start="5034" local_name_id="8" end="5037" id="728300_89" all_names="FDA" >FDA</NAME>

<NAME start="5055" local_name_id="14" end="5061" id="728300_90" all_names="CARACO" >Caraco</NAME>

<NAME start="5125" local_name_id="14" end="5131" id="728300_91" all_names="CARACO" >Caraco</NAME>

<NAME start="5230" local_name_id="13" end="5234" id="728300_92" all_names="NOVO" >Novo</NAME>

<ORGANIZATION start="5364" end="5378" id="728300_93" >District Court</ORGANIZATION>

<NAME start="5387" local_name_id="14" end="5393" id="728300_94" all_names="CARACO" >Caraco</NAME>

<NAME start="5424" local_name_id="17" end="5439" id="728300_95" all_names="FEDERAL CIRCUIT" >Federal Circuit</NAME>

<CITATION end="5949" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="5928" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="9" id="728300_55" citation_local_level_id="3" >566 U. S. ____ (2012)</CITATION>

<DATE start="5944" citation_global_level_id="2962.008" end="5948" id="728300_71" citation_local_level_id="3" >2012</DATE>

<CITATION party2="United States" party1="Johnson" citation_global_level_id="12071.001" party2_short="States" line="9" id="728300_59" alternative_keys="['u.s._559____']" end="6973" entry_type="party_key" lookup_key="johnsonstates#9" id1="2812210" start="6949" party1_short="Johnson" citation_local_level_id="4" >Johnson v. United States</CITATION>

<NAME end="6956" start="6949" party1_of="728300_59" all_names="JOHNSON" local_name_id="18" id="728300_63" >Johnson</NAME>

<NAME end="6973" start="6960" all_names="UNITED STATES" party2_of="728300_59" local_name_id="19" id="728300_64" >United States</NAME>

<CITATION alternative_keys="['johnsonstates#9']" end="6989" reporter="U. S." entry_type="standard_key" lookup_key="u.s._559____" id1="182514" volume="559" start="6975" page_number="___" standard_reporter="U.S." citation_global_level_id="2202.003" line="9" id="728300_56" citation_local_level_id="5" >559 U. S. ___</CITATION>

<CITATION party2="Medtronic, Inc" party1="Eli Lilly &amp; Co." citation_global_level_id="50579.003" party2_short="Medtronic" line="9" id="728300_60" alternative_keys="['u.s._496_661']" end="8543" entry_type="party_key" lookup_key="lillymedtronic#2" id1="112467" start="8510" party1_short="Lilly" citation_local_level_id="6" >Eli Lilly &amp; Co. v. Medtronic, Inc</CITATION>

<NAME end="8525" start="8510" party1_of="728300_60" all_names="ELI LILLY &amp; CO" local_name_id="20" id="728300_65" >Eli Lilly &amp; Co.</NAME>

<NAME end="8543" start="8529" all_names="MEDTRONIC INC" party2_of="728300_60" local_name_id="21" id="728300_66" >Medtronic, Inc</NAME>

<CITATION alternative_keys="['lillymedtronic#2']" end="8563" paragraph_number="665" reporter="U.S." entry_type="standard_key" lookup_key="u.s._496_661" id1="112467" volume="496" start="8546" page_number="661" standard_reporter="U.S." citation_global_level_id="50579.002" line="9" id="728300_57" citation_local_level_id="7" >496 U.S. 661, 665</CITATION>

<CITATION party2="INS" party1="Ardestani" citation_global_level_id="4658.001" party2_short="INS" line="9" id="728300_61" alternative_keys="['u.s._502_129']" end="8591" entry_type="party_key" lookup_key="ardestaniins#1" id1="112665" start="8575" party1_short="Ardestani" citation_local_level_id="8" >Ardestani v. INS</CITATION>

<NAME end="8584" start="8575" party1_of="728300_61" all_names="ARDESTANI	LIKEWISE IN ARDESTANI" local_name_id="22" id="728300_67" >Ardestani</NAME>

<NAME end="8591" start="8588" all_names="INS" party2_of="728300_61" local_name_id="23" id="728300_68" >INS</NAME>

<CITATION alternative_keys="['ardestaniins#1']" end="8610" paragraph_number="135" reporter="U.S." entry_type="standard_key" lookup_key="u.s._502_129" id1="112665" volume="502" start="8593" page_number="129" standard_reporter="U.S." citation_global_level_id="4658.002" line="9" id="728300_58" citation_local_level_id="9" >502 U.S. 129, 135</CITATION>

<CITATION party2="NOVO NORDISK A/S" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111066.001" party2_short="S" line="9" id="728300_62" end="9073" no_current_file="True" entry_type="party_key" lookup_key="laboratoriess#1" id1="Dummy_File_47216" start="8993" party1_short="LABORATORIES" citation_local_level_id="10" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S</CITATION>

<NAME end="9033" start="8993" party1_of="728300_62" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_69" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="9073" start="9057" all_names="NOVO NORDISK A/S" party2_of="728300_62" local_name_id="6" id="728300_70" >NOVO NORDISK A/S</NAME>

<NAME start="11215" local_name_id="13" end="11219" id="728300_115" all_names="NOVO" >Novo</NAME>

<NAME start="11239" local_name_id="12" end="11247" id="728300_116" all_names="CONGRESS" >Congress</NAME>

<NAME start="11368" local_name_id="7" end="11379" id="728300_117" all_names="ORANGE BOOK" >Orange Book</NAME>

<NAME start="11426" local_name_id="17" end="11441" id="728300_118" all_names="FEDERAL CIRCUIT" >Federal Circuit</NAME>

<CITATION party2="Thompson" party1="Mylan Pharmaceuticals, Inc." volume="268" citation_global_level_id="14930.005" party2_short="Thompson" line="10" id="728300_111" alternative_keys="['f.3d_268_1323', 'u.s._537_941']" end="11489" no_current_file="True" entry_type="party_key" lookup_key="pharmaceuticalsthompson#2" id1="124104" start="11450" page_number="1323" standard_reporter="F.3D" party1_short="Pharmaceuticals" citation_local_level_id="11" >Mylan Pharmaceuticals, Inc. v. Thompson</CITATION>

<NAME end="11477" start="11450" party1_of="728300_111" all_names="MYLAN PHARMACEUTICALS INC	FTC MYLAN PHARMACEUTICALS INC" local_name_id="24" id="728300_112" >Mylan Pharmaceuticals, Inc.</NAME>

<ORGANIZATION start="11450" end="11476" id="728300_119" >Mylan Pharmaceuticals, Inc</ORGANIZATION>

<NAME end="11489" start="11481" all_names="THOMPSON" party2_of="728300_111" local_name_id="25" id="728300_113" >Thompson</NAME>

<CITATION alternative_keys="['pharmaceuticalsthompson#2']" end="11508" reporter="F.3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_268_1323" id1="Dummy_File_47218" volume="268" start="11495" page_number="1323" standard_reporter="F.3D" citation_global_level_id="111068.003" line="10" id="728300_108" citation_local_level_id="12" >268 F.3d 1323</CITATION>

<CITATION end="12198" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="12177" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="10" id="728300_109" citation_local_level_id="13" >566 U. S. ____ (2012)</CITATION>

<DATE start="12193" citation_global_level_id="2962.008" end="12197" id="728300_114" citation_local_level_id="13" >2012</DATE>

<CITATION end="12593" reporter="F.3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_601_1359" id1="Dummy_File_47219" volume="601" start="12580" page_number="1359" standard_reporter="F.3D" citation_global_level_id="111069.001" line="10" id="728300_110" citation_local_level_id="14" >601 F.3d 1359</CITATION>

<CITATION end="12775" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="12754" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="13" id="728300_137" citation_local_level_id="15" >566 U. S. ____ (2012)</CITATION>

<DATE start="12770" citation_global_level_id="2962.008" end="12774" id="728300_146" citation_local_level_id="15" >2012</DATE>

<ORGANIZATION start="12836" end="12856" id="728300_150" >Opinion of the Court</ORGANIZATION>

<NAME start="12862" local_name_id="26" end="12868" id="728300_151" all_names="NOTICE" >NOTICE</NAME>

<NAME start="12968" local_name_id="27" end="12989" id="728300_152" all_names="UNITED STATES REPORTS" >United States Reports</NAME>

<NAME start="12991" local_name_id="28" end="12998" id="728300_153" all_names="READERS" >Readers</NAME>

<PROFESSION start="13031" end="13052" id="728300_154" >Reporter of Decisions</PROFESSION>

<ORGANIZATION start="13054" end="13088" id="728300_155" >Supreme Court of the United States</ORGANIZATION>

<NAME start="13090" local_name_id="29" end="13095" id="728300_156" all_names="WASH-" >Wash-</NAME>

<NAME start="13108" local_name_id="30" end="13112" id="728300_157" all_names="D C" >D. C</NAME>

<DATE start="13114" end="13118" id="728300_147" >2054</DATE>

<ORGANIZATION start="13254" end="13288" id="728300_158" >SUPREME COURT OF THE UNITED STATES</ORGANIZATION>

<DOCKET entry_type="docket" line="13" end="13386" id="728300_138" start="13380" >10–844</DOCKET>

<CITATION party2="NOVO NORDISK A/S ET AL" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL.," end="13529" party1_short="LABORATORIES" no_current_file="True" entry_type="party_key" party1_role="petitioners" lookup_key="laboratoriess#2" id1="Dummy_File_47220" start="13441" citation_global_level_id="111070.001" party2_short="S" line="13" id="728300_139" citation_local_level_id="16" >CARACO PHARMACEUTICAL LABORATORIES, LTD., ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL</CITATION>

<NAME end="13491" start="13441" party1_of="728300_139" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_141" >CARACO PHARMACEUTICAL LABORATORIES, LTD., ET AL.,</NAME>

<LEGAL_ROLE start="13492" end="13503" id="728300_143" >PETITIONERS</LEGAL_ROLE>

<NAME end="13529" start="13507" all_names="NOVO NORDISK A/S" party2_of="728300_139" local_name_id="6" id="728300_142" >NOVO NORDISK A/S ET AL</NAME>

<CITATION end="13627" line="13" id="728300_149" citation_global_level_id="98831.001" name="THE FEDERAL CIRCUIT" no_current_file="True" entry_type="case_key" lookup_key="the federal circuit#1" id1="Dummy_File_34981" start="13608" citation_local_level_id="17" >THE FEDERAL CIRCUIT</CITATION>

<DATE start="13661" end="13675" id="728300_148" >April 17, 2012</DATE>

<CITATION party2="NOVO NORDISK A/S                    Opinion of the Court" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111071.001" party2_short="Opinion" line="13" id="728300_140" end="14951" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#1" id1="Dummy_File_47221" start="14834" party1_short="LABORATORIES" citation_local_level_id="18" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="14874" start="14834" party1_of="728300_140" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_144" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="14951" start="14895" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_140" local_name_id="31" id="728300_145" >NOVO NORDISK A/S Opinion of the Court</NAME>

<NAME start="15367" local_name_id="8" end="15370" id="728300_388" all_names="FDA" >FDA</NAME>

<NAME start="15596" local_name_id="32" end="15599" id="728300_389" all_names="NDA" >NDA</NAME>

<NAME start="15608" local_name_id="8" end="15611" id="728300_390" all_names="FDA" >FDA</NAME>

<DATE start="16268" end="16272" id="728300_367" >1984</DATE>

<CITATION party2="Medtronic, Inc" party1="Eli Lilly &amp; Co." citation_global_level_id="50579.003" party2_short="Medtronic" line="23" id="728300_346" alternative_keys="['u.s._496_661']" end="16815" entry_type="party_key" lookup_key="lillymedtronic#2" id1="112467" start="16782" party1_short="Lilly" citation_local_level_id="19" >Eli Lilly &amp; Co. v. Medtronic, Inc</CITATION>

<NAME end="16797" start="16782" party1_of="728300_346" all_names="ELI LILLY &amp; CO" local_name_id="20" id="728300_353" >Eli Lilly &amp; Co.</NAME>

<NAME end="16815" start="16801" all_names="MEDTRONIC INC" party2_of="728300_346" local_name_id="21" id="728300_354" >Medtronic, Inc</NAME>

<CITATION alternative_keys="['lillymedtronic#2']" end="16842" paragraph_number="676" reporter="U.S." entry_type="standard_key" lookup_key="u.s._496_661" id1="112467" volume="496" start="16818" page_number="661" year="1990" standard_reporter="U.S." citation_global_level_id="50579.002" line="23" id="728300_331" citation_local_level_id="20" >496 U.S. 661, 676 (1990)</CITATION>

<DATE start="16837" citation_global_level_id="50579.002" end="16841" id="728300_368" citation_local_level_id="20" >1990</DATE>

<CITATION end="16892" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="16871" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="23" id="728300_332" citation_local_level_id="21" >566 U. S. ____ (2012)</CITATION>

<DATE start="16887" citation_global_level_id="2962.008" end="16891" id="728300_369" citation_local_level_id="21" >2012</DATE>

<DATE start="18113" end="18117" id="728300_370" >2011</DATE>

<CITATION party2="NOVO NORDISK A/S                     Opinion of the Court    See 21 U. S. C" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111072.001" party2_short="Opinion" line="23" id="728300_347" end="19074" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#2" id1="Dummy_File_47222" start="18937" party1_short="LABORATORIES" citation_local_level_id="22" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court See 21 U. S. C</CITATION>

<NAME end="18977" start="18937" party1_of="728300_347" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_355" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="19074" start="18999" all_names="U S C	NOVO NORDISK A/S OPINION OF THE COURT SEE 21 U S C" party2_of="728300_347" local_name_id="9" id="728300_356" >NOVO NORDISK A/S Opinion of the Court See 21 U. S. C</NAME>

<DATE start="20415" end="20419" id="728300_371" >2003</DATE>

<CITATION end="21198" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="21177" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="23" id="728300_333" citation_local_level_id="23" >566 U. S. ____ (2012)</CITATION>

<DATE start="21193" citation_global_level_id="2962.008" end="21197" id="728300_372" citation_local_level_id="23" >2012</DATE>

<DATE start="22940" end="22944" id="728300_373" >1990</DATE>

<CITATION party2="Thompson" party1="Apotex, Inc." volume="347" citation_global_level_id="111073.003" party2_short="Thompson" line="23" id="728300_348" alternative_keys="['f.3d_347_1335']" end="23098" no_current_file="True" entry_type="party_key" lookup_key="apotexthompson#1" id1="Dummy_File_47223" start="23074" page_number="1335" standard_reporter="F.3D" party1_short="Apotex" citation_local_level_id="24" >Apotex, Inc. v. Thompson</CITATION>

<NAME end="23086" start="23074" party1_of="728300_348" all_names="APOTEX INC" local_name_id="33" id="728300_357" >Apotex, Inc.</NAME>

<NAME end="23098" start="23090" all_names="THOMPSON" party2_of="728300_348" local_name_id="25" id="728300_358" >Thompson</NAME>

<CITATION alternative_keys="['apotexthompson#1']" end="23134" paragraph_number="1349" reporter="F.3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_347_1335" id1="Dummy_File_47223" volume="347" start="23100" page_number="1335" year="2003" standard_reporter="F.3D" citation_global_level_id="111073.003" line="23" id="728300_334" citation_local_level_id="25" >347 F.3d 1335, 1349 (CA Fed. 2003)</CITATION>

<DATE start="23129" citation_global_level_id="111073.003" end="23133" id="728300_374" citation_local_level_id="25" >2003</DATE>

<CITATION end="23177" paragraph_number="242" reporter="F.3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_296_227" id1="Dummy_File_47224" volume="296" start="23160" page_number="227" standard_reporter="F.3D" citation_global_level_id="111074.001" line="23" id="728300_335" citation_local_level_id="26" >296 F.3d 227, 242</CITATION>

<DATE start="23187" end="23191" id="728300_375" >2002</DATE>

<CITATION party2="NOVO NORDISK A/S                  Opinion of the Court" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111075.001" party2_short="Opinion" line="23" id="728300_349" end="23377" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#3" id1="Dummy_File_47225" start="23262" party1_short="LABORATORIES" citation_local_level_id="27" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="23302" start="23262" party1_of="728300_349" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_359" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="23377" start="23323" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_349" local_name_id="31" id="728300_360" >NOVO NORDISK A/S Opinion of the Court</NAME>

<DATE start="23653" end="23662" id="728300_376" >July 2002</DATE>

<CITATION party2="Thompson" party1="FTC, Mylan Pharmaceuticals, Inc." citation_global_level_id="14930.005" party2_short="Thompson" line="23" id="728300_350" alternative_keys="['f.3d_268_1323', 'u.s._537_941']" end="23859" no_current_file="True" entry_type="party_key" lookup_key="pharmaceuticalsthompson#2" id1="124104" start="23815" party1_short="Pharmaceuticals" citation_local_level_id="28" >FTC, Mylan Pharmaceuticals, Inc. v. Thompson</CITATION>

<NAME end="23847" start="23815" party1_of="728300_350" all_names="MYLAN PHARMACEUTICALS INC	FTC MYLAN PHARMACEUTICALS INC" local_name_id="24" id="728300_361" >FTC, Mylan Pharmaceuticals, Inc.</NAME>

<NAME end="23859" start="23851" all_names="THOMPSON" party2_of="728300_350" local_name_id="25" id="728300_362" >Thompson</NAME>

<CITATION alternative_keys="['pharmaceuticalsthompson#2']" end="23889" reporter="F.3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_268_1323" id1="Dummy_File_47218" volume="268" start="23861" page_number="1323" year="2001" standard_reporter="F.3D" citation_global_level_id="111068.003" line="23" id="728300_336" citation_local_level_id="29" >268 F.3d 1323 (CA Fed. 2001)</CITATION>

<DATE start="23884" citation_global_level_id="111068.003" end="23888" id="728300_377" citation_local_level_id="29" >2001</DATE>

<DATE start="24966" end="24970" id="728300_378" >2003</DATE>

<CITATION end="25341" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="25320" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="23" id="728300_337" citation_local_level_id="30" >566 U. S. ____ (2012)</CITATION>

<DATE start="25336" citation_global_level_id="2962.008" end="25340" id="728300_379" citation_local_level_id="30" >2012</DATE>

<DATE start="26477" end="26481" id="728300_380" >2009</DATE>

<DATE start="26486" end="26490" id="728300_381" >2004</DATE>

<DATE start="26600" end="26604" id="728300_382" >2018</DATE>

<CITATION end="26784" paragraph_number="1362" reporter="F.3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_601_1359" id1="Dummy_File_47219" volume="601" start="26750" page_number="1359" year="2010" standard_reporter="F.3D" citation_global_level_id="111069.001" line="23" id="728300_338" citation_local_level_id="31" >601 F.3d 1359, 1362 (CA Fed. 2010)</CITATION>

<DATE start="26779" citation_global_level_id="111069.001" end="26783" id="728300_383" citation_local_level_id="31" >2010</DATE>

<DATE start="26986" end="26990" id="728300_384" >2005</DATE>

<CITATION party2="NOVO NORDISK A/S                   Opinion of the Court" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111075.001" party2_short="Opinion" line="23" id="728300_351" end="27270" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#3" id1="Dummy_File_47225" start="27153" party1_short="LABORATORIES" citation_local_level_id="32" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="27193" start="27153" party1_of="728300_351" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_363" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="27270" start="27215" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_351" local_name_id="31" id="728300_364" >NOVO NORDISK A/S Opinion of the Court</NAME>

<CITATION end="27989" reporter="F. 3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_601_1362" id1="Dummy_File_47226" volume="601" start="27971" page_number="1362" standard_reporter="F.3D" citation_global_level_id="111076.001" line="23" id="728300_339" citation_local_level_id="33" >601 F. 3d, at 1362</CITATION>

<DATE start="28294" end="28298" id="728300_385" >2008</DATE>

<CITATION end="28644" reporter="F. 3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_601_1363" id1="Dummy_File_47227" volume="601" start="28626" page_number="1363" standard_reporter="F.3D" citation_global_level_id="111077.001" line="23" id="728300_340" citation_local_level_id="34" >601 F. 3d, at 1363</CITATION>

<CITATION end="29324" reporter="F. 3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_601_1380" id1="Dummy_File_47228" volume="601" start="29306" page_number="1380" standard_reporter="F.3D" citation_global_level_id="111078.001" line="23" id="728300_341" citation_local_level_id="35" >601 F. 3d, at 1380</CITATION>

<CITATION end="29379" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="29358" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="23" id="728300_342" citation_local_level_id="36" >566 U. S. ____ (2012)</CITATION>

<DATE start="29374" citation_global_level_id="2962.008" end="29378" id="728300_386" citation_local_level_id="36" >2012</DATE>

<CITATION end="30561" reporter="a" entry_type="standard_key" no_current_file="True" lookup_key="a._65_66" id1="Dummy_File_47229" volume="65" start="30555" page_number="66" standard_reporter="A." citation_global_level_id="111079.001" line="23" id="728300_343" citation_local_level_id="37" >65a–66</CITATION>

<CITATION end="30689" reporter="F. 3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_601_1360" id1="Dummy_File_47230" volume="601" start="30671" page_number="1360" standard_reporter="F.3D" citation_global_level_id="111080.001" line="23" id="728300_344" citation_local_level_id="38" >601 F. 3d, at 1360</CITATION>

<CITATION party2="NOVO NORDISK A/S                      Opinion of the Court  1366–1367. Judge Dyk" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111081.001" party2_short="Opinion" line="23" id="728300_352" end="31555" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#4" id1="Dummy_File_47231" start="31410" party1_short="LABORATORIES" citation_local_level_id="39" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court 1366–1367. Judge Dyk</CITATION>

<NAME end="31450" start="31410" party1_of="728300_352" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_365" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="31555" start="31475" all_names="NOVO NORDISK A/S OPINION OF THE COURT 1366–1367 JUDGE DYK" party2_of="728300_352" local_name_id="34" id="728300_366" >NOVO NORDISK A/S Opinion of the Court 1366–1367. Judge Dyk</NAME>

<CITATION end="32017" reporter="U. S." entry_type="standard_key" lookup_key="u.s._564____" id1="855517" volume="564" start="31997" page_number="___" year="2011" standard_reporter="U.S." citation_global_level_id="2290.003" line="23" id="728300_345" citation_local_level_id="40" >564 U. S. ___ (2011)</CITATION>

<DATE start="32012" citation_global_level_id="2290.003" end="32016" id="728300_387" citation_local_level_id="40" >2011</DATE>

<CITATION party2="Ron Pair Enterprises" party1="United States" citation_global_level_id="51673.001" party2_short="Enterprises" line="24" id="728300_420" end="32196" entry_type="party_key" lookup_key="statesenterprises#2" id1="112204" start="32159" party1_short="States" citation_local_level_id="41" >United States v. Ron Pair Enterprises</CITATION>

<NAME end="32172" start="32159" party1_of="728300_420" all_names="UNITED STATES" local_name_id="19" id="728300_422" >United States</NAME>

<NAME end="32196" start="32176" all_names="RON PAIR ENTERPRISES" party2_of="728300_420" local_name_id="35" id="728300_423" >Ron Pair Enterprises</NAME>

<CITATION end="32228" paragraph_number="241" reporter="U.S." entry_type="standard_key" lookup_key="u.s._489_235" id1="112204" volume="489" start="32204" page_number="235" year="1989" standard_reporter="U.S." citation_global_level_id="51673.002" line="24" id="728300_417" citation_local_level_id="42" >489 U.S. 235, 241 (1989)</CITATION>

<DATE start="32223" citation_global_level_id="51673.002" end="32227" id="728300_426" citation_local_level_id="42" >1989</DATE>

<CITATION party2="Shell Oil Co" party1="Robinson" citation_global_level_id="38324.001" party2_short="Oil" line="24" id="728300_421" alternative_keys="['u.s._519_337']" end="32828" entry_type="party_key" lookup_key="robinsonoil#1" id1="118082" start="32804" party1_short="Robinson" citation_local_level_id="43" >Robinson v. Shell Oil Co</CITATION>

<NAME end="32812" start="32804" party1_of="728300_421" all_names="ROBINSON" local_name_id="36" id="728300_424" >Robinson</NAME>

<NAME end="32828" start="32816" all_names="SHELL OIL CO" party2_of="728300_421" local_name_id="37" id="728300_425" >Shell Oil Co</NAME>

<CITATION alternative_keys="['robinsonoil#1']" end="32855" paragraph_number="341" reporter="U.S." entry_type="standard_key" lookup_key="u.s._519_337" id1="213842" volume="519" start="32831" page_number="337" year="1997" standard_reporter="U.S." citation_global_level_id="3575.004" line="24" id="728300_418" citation_local_level_id="44" >519 U.S. 337, 341 (1997)</CITATION>

<DATE start="32850" citation_global_level_id="3575.004" end="32854" id="728300_427" citation_local_level_id="44" >1997</DATE>

<CITATION end="33397" reporter="F. Supp. 2d" entry_type="standard_key" no_current_file="True" lookup_key="f.supp.2d_775_985" id1="Dummy_File_47232" volume="775" start="33362" page_number="985" year="2011" standard_reporter="F.SUPP.2D" citation_global_level_id="111082.001" line="24" id="728300_419" citation_local_level_id="45" >775 F. Supp. 2d 985 (ED Mich. 2011)</CITATION>

<DATE start="33392" citation_global_level_id="111082.001" end="33396" id="728300_428" citation_local_level_id="45" >2011</DATE>

<CITATION end="33539" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="33518" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="34" id="728300_615" citation_local_level_id="46" >566 U. S. ____ (2012)</CITATION>

<DATE start="33534" citation_global_level_id="2962.008" end="33538" id="728300_660" citation_local_level_id="46" >2012</DATE>

<ORGANIZATION start="33589" end="33609" id="728300_675" >Opinion of the Court</ORGANIZATION>

<CITATION party2="Marshall" party1="Stern" citation_global_level_id="19289.001" party2_short="Marshall" line="34" id="728300_630" alternative_keys="['u.s._564____']" end="35694" entry_type="party_key" lookup_key="sternmarshall#1" id1="219617" start="35677" party1_short="Stern" citation_local_level_id="47" >Stern v. Marshall</CITATION>

<NAME end="35682" start="35677" party1_of="728300_630" all_names="STERN" local_name_id="38" id="728300_640" >Stern</NAME>

<NAME end="35694" start="35686" all_names="MARSHALL" party2_of="728300_630" local_name_id="39" id="728300_641" >Marshall</NAME>

<CITATION alternative_keys="['sternmarshall#1']" end="35709" reporter="U. S." entry_type="standard_key" lookup_key="u.s._564____" id1="855517" volume="564" start="35696" page_number="___" standard_reporter="U.S." citation_global_level_id="2290.003" line="34" id="728300_616" citation_local_level_id="48" >564 U. S. ___</CITATION>

<DATE start="35716" end="35720" id="728300_661" >2011</DATE>

<CITATION party2="NOVO NORDISK A/S                     Opinion of the Court" party1="U. S. C. §1338(a).  12    CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111072.001" party2_short="Opinion" line="34" id="728300_631" end="36061" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#2" id1="Dummy_File_47222" start="35916" party1_short="LABORATORIES" citation_local_level_id="49" >U. S. C. §1338(a). 12 CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="35982" start="35916" party1_of="728300_631" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_642" >U. S. C. §1338(a). 12 CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="36061" start="36004" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_631" local_name_id="31" id="728300_643" >NOVO NORDISK A/S Opinion of the Court</NAME>

<CITATION party2="United States" party1="Johnson" citation_global_level_id="12071.001" party2_short="States" line="34" id="728300_632" alternative_keys="['u.s._559____']" end="36319" entry_type="party_key" lookup_key="johnsonstates#9" id1="2812210" start="36295" party1_short="Johnson" citation_local_level_id="50" >Johnson v. United States</CITATION>

<NAME end="36302" start="36295" party1_of="728300_632" all_names="JOHNSON" local_name_id="18" id="728300_644" >Johnson</NAME>

<NAME end="36319" start="36306" all_names="UNITED STATES" party2_of="728300_632" local_name_id="19" id="728300_645" >United States</NAME>

<CITATION alternative_keys="['johnsonstates#9']" end="36334" reporter="U. S." entry_type="standard_key" lookup_key="u.s._559____" id1="182514" volume="559" start="36321" page_number="___" standard_reporter="U.S." citation_global_level_id="2202.003" line="34" id="728300_617" citation_local_level_id="51" >559 U. S. ___</CITATION>

<DATE start="36341" end="36345" id="728300_662" >2010</DATE>

<DATE start="37958" end="37962" id="728300_663" >2001</DATE>

<CITATION party2="AT&amp;T Inc" party1="FCC" citation_global_level_id="3575.01" party2_short="T" line="34" id="728300_633" alternative_keys="['u.s._562____']" end="38026" entry_type="party_key" lookup_key="fcct#1" id1="213842" start="38011" party1_short="FCC" citation_local_level_id="52" >FCC v. AT&amp;T Inc</CITATION>

<NAME end="38014" start="38011" party1_of="728300_633" all_names="FCC" local_name_id="40" id="728300_646" >FCC</NAME>

<NAME end="38026" start="38018" all_names="AT&amp;T INC" party2_of="728300_633" local_name_id="41" id="728300_647" >AT&amp;T Inc</NAME>

<CITATION alternative_keys="['fcct#1']" end="38042" reporter="U. S." entry_type="standard_key" lookup_key="u.s._562____" id1="213842" volume="562" start="38029" page_number="___" standard_reporter="U.S." citation_global_level_id="3575.002" line="34" id="728300_618" citation_local_level_id="53" >562 U. S. ___</CITATION>

<DATE start="38049" end="38053" id="728300_664" >2011</DATE>

<CITATION end="38208" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="38187" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="34" id="728300_619" citation_local_level_id="54" >566 U. S. ____ (2012)</CITATION>

<DATE start="38203" citation_global_level_id="2962.008" end="38207" id="728300_665" citation_local_level_id="54" >2012</DATE>

<CITATION end="38710" line="34" id="728300_674" citation_global_level_id="111083.001" name="The Hatch-Waxman Amendments" no_current_file="True" entry_type="case_key" lookup_key="the hatch-waxman amendments#1" id1="Dummy_File_47233" start="38683" citation_local_level_id="55" >The Hatch-Waxman Amendments</CITATION>

<CITATION party2="NOVO NORDISK A/S                    Opinion of the Court" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111071.001" party2_short="Opinion" line="34" id="728300_634" end="40377" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#1" id1="Dummy_File_47221" start="40260" party1_short="LABORATORIES" citation_local_level_id="56" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="40300" start="40260" party1_of="728300_634" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_648" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="40377" start="40321" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_634" local_name_id="31" id="728300_649" >NOVO NORDISK A/S Opinion of the Court</NAME>

<CITATION end="41009" reporter="U. S." entry_type="standard_key" no_current_file="True" lookup_key="u.s._496_673" id1="Dummy_File_47234" volume="496" start="40992" page_number="673" standard_reporter="U.S." citation_global_level_id="111084.001" line="34" id="728300_620" citation_local_level_id="57" >496 U. S., at 673</CITATION>

<CITATION end="42437" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="42416" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="34" id="728300_621" citation_local_level_id="58" >566 U. S. ____ (2012)</CITATION>

<DATE start="42432" citation_global_level_id="2962.008" end="42436" id="728300_666" citation_local_level_id="58" >2012</DATE>

<CITATION party2="NOVO NORDISK A/S                   Opinion of the Court     The" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111085.001" party2_short="Opinion" line="34" id="728300_635" end="44757" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#5" id1="Dummy_File_47235" start="44632" party1_short="LABORATORIES" citation_local_level_id="59" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court The</CITATION>

<NAME end="44672" start="44632" party1_of="728300_635" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_650" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="44757" start="44694" all_names="NOVO NORDISK A/S OPINION OF THE COURT THE" party2_of="728300_635" local_name_id="42" id="728300_651" >NOVO NORDISK A/S Opinion of the Court The</NAME>

<CITATION end="46208" reporter="U. S." entry_type="standard_key" no_current_file="True" lookup_key="u.s._496_665" id1="Dummy_File_47236" volume="496" start="46191" page_number="665" standard_reporter="U.S." citation_global_level_id="111086.001" line="34" id="728300_622" citation_local_level_id="60" >496 U. S., at 665</CITATION>

<CITATION end="46930" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="46909" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="34" id="728300_623" citation_local_level_id="61" >566 U. S. ____ (2012)</CITATION>

<DATE start="46925" citation_global_level_id="2962.008" end="46929" id="728300_667" citation_local_level_id="61" >2012</DATE>

<CITATION alternative_keys="['ardestaniins#1', 'u.s._502_129']" end="47232" reporter="U. S." entry_type="standard_key" lookup_key="u.s._496_667" id1="112665" volume="496" start="47215" page_number="667" standard_reporter="U.S." citation_global_level_id="4658.005" line="34" id="728300_624" citation_local_level_id="62" >496 U. S., at 667</CITATION>

<CITATION party2="INS" party1="Likewise, in Ardestani" citation_global_level_id="4658.001" party2_short="INS" line="34" id="728300_636" alternative_keys="['u.s._496_667', 'u.s._502_129']" end="47263" entry_type="party_key" lookup_key="ardestaniins#1" id1="112665" start="47234" party1_short="Ardestani" citation_local_level_id="63" >Likewise, in Ardestani v. INS</CITATION>

<NAME end="47256" start="47234" party1_of="728300_636" all_names="ARDESTANI	LIKEWISE IN ARDESTANI" local_name_id="22" id="728300_652" >Likewise, in Ardestani</NAME>

<NAME end="47263" start="47260" all_names="INS" party2_of="728300_636" local_name_id="23" id="728300_653" >INS</NAME>

<CITATION alternative_keys="['u.s._496_667', 'ardestaniins#1']" end="47289" paragraph_number="135" reporter="U.S." entry_type="standard_key" lookup_key="u.s._502_129" id1="112665" volume="502" start="47265" page_number="129" year="1991" standard_reporter="U.S." citation_global_level_id="4658.002" line="34" id="728300_625" citation_local_level_id="64" >502 U.S. 129, 135 (1991)</CITATION>

<DATE start="47284" citation_global_level_id="4658.002" end="47288" id="728300_668" citation_local_level_id="64" >1991</DATE>

<CITATION alternative_keys="['ardestaniins#1', 'u.s._502_129']" end="47749" reporter="U. S." entry_type="standard_key" lookup_key="u.s._496_667" id1="112665" volume="496" start="47732" page_number="667" standard_reporter="U.S." citation_global_level_id="4658.005" line="34" id="728300_626" citation_local_level_id="65" >496 U. S., at 667</CITATION>

<CITATION end="47972" reporter="U. S." entry_type="standard_key" no_current_file="True" lookup_key="u.s._502_135" id1="Dummy_File_47237" volume="502" start="47955" page_number="135" standard_reporter="U.S." citation_global_level_id="111087.001" line="34" id="728300_627" citation_local_level_id="66" >502 U. S., at 135</CITATION>

<CITATION party2="NOVO NORDISK A/S                  Opinion of the Court" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111075.001" party2_short="Opinion" line="34" id="728300_637" end="49092" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#3" id1="Dummy_File_47225" start="48977" party1_short="LABORATORIES" citation_local_level_id="67" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="49017" start="48977" party1_of="728300_637" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_654" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="49092" start="49038" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_637" local_name_id="31" id="728300_655" >NOVO NORDISK A/S Opinion of the Court</NAME>

<CITATION end="51060" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="51039" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="34" id="728300_628" citation_local_level_id="68" >566 U. S. ____ (2012)</CITATION>

<DATE start="51055" citation_global_level_id="2962.008" end="51059" id="728300_669" citation_local_level_id="68" >2012</DATE>

<CITATION party2="Andrews" party1="TRW Inc." citation_global_level_id="19987.001" party2_short="Andrews" line="34" id="728300_638" alternative_keys="['u.s._534_19']" end="52301" entry_type="party_key" lookup_key="trwandrews#1" id1="118465" start="52282" party1_short="TRW" citation_local_level_id="69" >TRW Inc. v. Andrews</CITATION>

<NAME end="52290" start="52282" party1_of="728300_638" all_names="TRW INC" local_name_id="43" id="728300_656" >TRW Inc.</NAME>

<NAME end="52301" start="52294" all_names="ANDREWS" party2_of="728300_638" local_name_id="44" id="728300_657" >Andrews</NAME>

<CITATION alternative_keys="['trwandrews#1']" end="52325" paragraph_number="31" reporter="U.S." entry_type="standard_key" lookup_key="u.s._534_19" id1="118465" volume="534" start="52303" page_number="19" year="2001" standard_reporter="U.S." citation_global_level_id="19987.002" line="34" id="728300_629" citation_local_level_id="70" >534 U.S. 19, 31 (2001)</CITATION>

<DATE start="52320" citation_global_level_id="19987.002" end="52324" id="728300_670" citation_local_level_id="70" >2001</DATE>

<DATE start="53100" end="53104" id="728300_671" >2018</DATE>

<DATE start="53117" end="53121" id="728300_672" >2015</DATE>

<CITATION party2="NOVO NORDISK A/S                  Opinion of the Court" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111075.001" party2_short="Opinion" line="34" id="728300_639" end="53257" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#3" id1="Dummy_File_47225" start="53142" party1_short="LABORATORIES" citation_local_level_id="71" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="53182" start="53142" party1_of="728300_639" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_658" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="53257" start="53203" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_639" local_name_id="31" id="728300_659" >NOVO NORDISK A/S Opinion of the Court</NAME>

<DATE start="53538" end="53542" id="728300_673" >2018</DATE>

<NAME start="53984" local_name_id="13" end="53988" id="728300_770" all_names="NOVO" >Novo</NAME>

<NAME start="54273" local_name_id="45" end="54283" id="728300_771" all_names="NOVO FIRST" >Novo first</NAME>

<LEGAL_ROLE start="54396" end="54417" plural="True" id="728300_772" >Brief for Respondents</LEGAL_ROLE>

<CITATION party2="United States" party1="Smith" citation_global_level_id="7101.001" party2_short="States" line="39" id="728300_748" alternative_keys="['u.s._507_197']" end="54452" entry_type="party_key" lookup_key="smithstates#9" id1="124024" start="54430" party1_short="Smith" citation_local_level_id="72" >Smith v. United States</CITATION>

<NAME end="54435" start="54430" party1_of="728300_748" all_names="SMITH" local_name_id="46" id="728300_752" >Smith</NAME>

<NAME end="54452" start="54439" all_names="UNITED STATES" party2_of="728300_748" local_name_id="19" id="728300_753" >United States</NAME>

<CITATION alternative_keys="['smithstates#9']" end="54471" paragraph_number="203" reporter="U.S." entry_type="standard_key" lookup_key="u.s._507_197" id1="112827" volume="507" start="54454" page_number="197" standard_reporter="U.S." citation_global_level_id="4656.002" line="39" id="728300_742" citation_local_level_id="73" >507 U.S. 197, 203</CITATION>

<DATE start="54479" end="54483" id="728300_760" >1993</DATE>

<DATE start="54490" end="54494" id="728300_761" >2002</DATE>

<CITATION end="54982" line="39" id="728300_768" citation_global_level_id="106253.001" name="The Senate" no_current_file="True" entry_type="case_key" lookup_key="the senate#1" id1="Dummy_File_42403" start="54972" citation_local_level_id="74" >The Senate</CITATION>

<CITATION end="55136" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="55115" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="39" id="728300_743" citation_local_level_id="75" >566 U. S. ____ (2012)</CITATION>

<DATE start="55131" citation_global_level_id="2962.008" end="55135" id="728300_762" citation_local_level_id="75" >2012</DATE>

<CITATION party2="Army Corps of Engineers" party1="Solid Waste Agency of Northern Cook Cty." citation_global_level_id="46049.001" party2_short="Corps" line="39" id="728300_749" alternative_keys="['u.s._531_159']" end="55867" entry_type="party_key" lookup_key="agencycorps#1" id1="118396" start="55800" party1_short="Agency" citation_local_level_id="76" >Solid Waste Agency of Northern Cook Cty. v. Army Corps of Engineers</CITATION>

<NAME end="55840" start="55800" party1_of="728300_749" all_names="SOLID WASTE AGENCY OF NORTHERN COOK CTY" local_name_id="47" id="728300_754" >Solid Waste Agency of Northern Cook Cty.</NAME>

<NAME end="55867" start="55844" all_names="ARMY CORPS OF ENGINEERS" party2_of="728300_749" local_name_id="48" id="728300_755" >Army Corps of Engineers</NAME>

<CITATION alternative_keys="['agencycorps#1']" end="55893" paragraph_number="170" reporter="U.S." entry_type="standard_key" lookup_key="u.s._531_159" id1="118396" volume="531" start="55869" page_number="159" year="2001" standard_reporter="U.S." citation_global_level_id="46049.002" line="39" id="728300_744" citation_local_level_id="77" >531 U.S. 159, 170 (2001)</CITATION>

<DATE start="55888" citation_global_level_id="46049.002" end="55892" id="728300_763" citation_local_level_id="77" >2001</DATE>

<DATE start="56742" end="56746" id="728300_764" >2002</DATE>

<DATE start="57129" end="57133" id="728300_765" >2003</DATE>

<CITATION party2="NOVO NORDISK A/S                    Opinion of the Court" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111071.001" party2_short="Opinion" line="39" id="728300_750" end="57497" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#1" id1="Dummy_File_47221" start="57380" party1_short="LABORATORIES" citation_local_level_id="78" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court</CITATION>

<NAME end="57420" start="57380" party1_of="728300_750" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_756" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="57497" start="57441" all_names="NOVO NORDISK A/S OPINION OF THE COURT" party2_of="728300_750" local_name_id="31" id="728300_757" >NOVO NORDISK A/S Opinion of the Court</NAME>

<CITATION alternative_keys="['pharmaceuticalsthompson#2']" end="57986" reporter="F.3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_268_1323" id1="Dummy_File_47218" volume="268" start="57973" page_number="1323" standard_reporter="F.3D" citation_global_level_id="111068.003" line="39" id="728300_745" citation_local_level_id="79" >268 F.3d 1323</CITATION>

<CITATION end="58304" line="39" id="728300_769" citation_global_level_id="98831.001" name="The Federal Circuit" no_current_file="True" entry_type="case_key" lookup_key="the federal circuit#1" id1="Dummy_File_34981" start="58285" citation_local_level_id="80" >The Federal Circuit</CITATION>

<CITATION end="59206" reporter="U. S." entry_type="standard_key" no_current_file="True" lookup_key="u.s._496_670" id1="Dummy_File_47238" volume="496" start="59189" page_number="670" standard_reporter="U.S." citation_global_level_id="111088.001" line="39" id="728300_746" citation_local_level_id="81" >496 U. S., at 670</CITATION>

<CITATION end="59457" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="59436" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="39" id="728300_747" citation_local_level_id="82" >566 U. S. ____ (2012)</CITATION>

<DATE start="59452" citation_global_level_id="2962.008" end="59456" id="728300_766" citation_local_level_id="82" >2012</DATE>

<DATE start="60900" end="60904" id="728300_767" >2018</DATE>

<CITATION party2="NOVO NORDISK A/S                    Opinion of the Court    Tr. of Oral Arg" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111071.001" party2_short="Opinion" line="39" id="728300_751" end="61724" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesopinion#1" id1="Dummy_File_47221" start="61588" party1_short="LABORATORIES" citation_local_level_id="83" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S Opinion of the Court Tr. of Oral Arg</CITATION>

<NAME end="61628" start="61588" party1_of="728300_751" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_758" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="61724" start="61649" all_names="NOVO NORDISK A/S OPINION OF THE COURT TR OF ORAL ARG" party2_of="728300_751" local_name_id="49" id="728300_759" >NOVO NORDISK A/S Opinion of the Court Tr. of Oral Arg</NAME>

<ORGANIZATION start="62638" end="62644" plural="True" id="728300_786" >courts</ORGANIZATION>

<NAME start="62684" local_name_id="8" end="62687" id="728300_787" all_names="FDA" >FDA</NAME>

<ORGANIZATION start="62845" end="62852" id="728300_788" >company</ORGANIZATION>

<NAME start="62949" local_name_id="14" end="62955" id="728300_789" all_names="CARACO" >Caraco</NAME>

<NAME start="63004" local_name_id="13" end="63008" id="728300_790" all_names="NOVO" >Novo</NAME>

<ORGANIZATION start="63169" end="63185" id="728300_791" >Court of Appeals</ORGANIZATION>

<CITATION end="63389" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="63368" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="42" id="728300_792" citation_local_level_id="84" >566 U. S. ____ (2012)</CITATION>

<DATE start="63384" citation_global_level_id="2962.008" end="63388" id="728300_793" citation_local_level_id="84" >2012</DATE>

<NAME start="63423" local_name_id="50" end="63432" id="728300_794" all_names="SOTOMAYOR" >SOTOMAYOR</NAME>

<ORGANIZATION start="63450" end="63484" id="728300_795" >SUPREME COURT OF THE UNITED STATES</ORGANIZATION>

<DOCKET end="63567" no_current_file="True" entry_type="docket" lookup_key="laboratoriess#2" id1="Dummy_File_47220" start="63561" citation_global_level_id="111070.001" line="47" id="728300_837" citation_local_level_id="16" >10–844</DOCKET>

<CITATION party2="NOVO NORDISK A/S ET AL" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL.," end="63702" party1_short="LABORATORIES" no_current_file="True" entry_type="party_key" party1_role="petitioners" lookup_key="laboratoriess#2" id1="Dummy_File_47220" start="63614" citation_global_level_id="111070.001" party2_short="S" line="47" id="728300_838" citation_local_level_id="85" >CARACO PHARMACEUTICAL LABORATORIES, LTD., ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL</CITATION>

<NAME end="63664" start="63614" party1_of="728300_838" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_842" >CARACO PHARMACEUTICAL LABORATORIES, LTD., ET AL.,</NAME>

<ORGANIZATION start="63614" end="63653" id="728300_855" >CARACO PHARMACEUTICAL LABORATORIES, LTD</ORGANIZATION>

<LEGAL_ROLE start="63665" end="63676" id="728300_844" >PETITIONERS</LEGAL_ROLE>

<NAME end="63702" start="63680" all_names="NOVO NORDISK A/S" party2_of="728300_838" local_name_id="6" id="728300_843" >NOVO NORDISK A/S ET AL</NAME>

<CITATION end="63800" line="47" id="728300_854" citation_global_level_id="98831.001" name="THE FEDERAL CIRCUIT" no_current_file="True" entry_type="case_key" lookup_key="the federal circuit#1" id1="Dummy_File_34981" start="63781" citation_local_level_id="86" >THE FEDERAL CIRCUIT</CITATION>

<DATE start="63827" end="63841" id="728300_851" >April 17, 2012</DATE>

<CITATION party2="Medtronic, Inc" party1="Eli Lilly &amp; Co." citation_global_level_id="50579.003" party2_short="Medtronic" line="47" id="728300_839" alternative_keys="['u.s._496_661']" end="64635" entry_type="party_key" lookup_key="lillymedtronic#2" id1="112467" start="64602" party1_short="Lilly" citation_local_level_id="87" >Eli Lilly &amp; Co. v. Medtronic, Inc</CITATION>

<NAME end="64617" start="64602" party1_of="728300_839" all_names="ELI LILLY &amp; CO" local_name_id="20" id="728300_845" >Eli Lilly &amp; Co.</NAME>

<NAME end="64635" start="64621" all_names="MEDTRONIC INC" party2_of="728300_839" local_name_id="21" id="728300_846" >Medtronic, Inc</NAME>

<CITATION alternative_keys="['lillymedtronic#2']" end="64662" paragraph_number="676" reporter="U.S." entry_type="standard_key" lookup_key="u.s._496_661" id1="112467" volume="496" start="64638" page_number="661" year="1990" standard_reporter="U.S." citation_global_level_id="50579.002" line="47" id="728300_835" citation_local_level_id="88" >496 U.S. 661, 676 (1990)</CITATION>

<DATE start="64657" citation_global_level_id="50579.002" end="64661" id="728300_852" citation_local_level_id="88" >1990</DATE>

<CITATION party2="NOVO NORDISK A/S                   SOTOMAYOR, J" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111089.001" party2_short="J" line="47" id="728300_840" end="65270" no_current_file="True" entry_type="party_key" lookup_key="laboratoriesj#1" id1="Dummy_File_47239" start="65160" party1_short="LABORATORIES" citation_local_level_id="89" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S SOTOMAYOR, J</CITATION>

<NAME end="65200" start="65160" party1_of="728300_840" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_847" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="65270" start="65223" all_names="NOVO NORDISK A/S SOTOMAYOR J" party2_of="728300_840" local_name_id="51" id="728300_848" >NOVO NORDISK A/S SOTOMAYOR, J</NAME>

<CITATION end="67333" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="67312" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="47" id="728300_836" citation_local_level_id="90" >566 U. S. ____ (2012)</CITATION>

<DATE start="67328" citation_global_level_id="2962.008" end="67332" id="728300_853" citation_local_level_id="90" >2012</DATE>

<CITATION party2="NOVO NORDISK A/S" party1="CARACO PHARMACEUTICAL LABORATORIES, LTD." citation_global_level_id="111070.001" party2_short="S" line="47" id="728300_841" end="69385" no_current_file="True" entry_type="party_key" lookup_key="laboratoriess#2" id1="Dummy_File_47220" start="69306" party1_short="LABORATORIES" citation_local_level_id="91" >CARACO PHARMACEUTICAL LABORATORIES, LTD. v. NOVO NORDISK A/S</CITATION>

<NAME end="69346" start="69306" party1_of="728300_841" all_names="CARACO PHARMACEUTICAL LABORATORIES LTD	U S C §1338(A) 12 CARACO PHARMACEUTICAL LABORATORIES LTD" local_name_id="5" id="728300_849" >CARACO PHARMACEUTICAL LABORATORIES, LTD.</NAME>

<NAME end="69385" start="69369" all_names="NOVO NORDISK A/S" party2_of="728300_841" local_name_id="6" id="728300_850" >NOVO NORDISK A/S</NAME>

<NAME start="69404" local_name_id="50" end="69413" id="728300_870" all_names="SOTOMAYOR" >SOTOMAYOR</NAME>

<LEGAL_ROLE start="69481" end="69491" plural="True" id="728300_871" >applicants</LEGAL_ROLE>

<LEGAL_ROLE start="69578" end="69587" id="728300_872" >applicant</LEGAL_ROLE>

<NAME start="69614" local_name_id="52" end="69617" id="728300_873" all_names="APP" >App</NAME>

<CITATION end="69823" reporter="a" entry_type="standard_key" no_current_file="True" lookup_key="a._213_240" id1="Dummy_File_47240" volume="213" start="69761" page_number="240" standard_reporter="A." citation_global_level_id="111090.001" line="48" id="728300_868" citation_local_level_id="92" >213a, and else- where FDA acknowledges “that in some cases 240</CITATION>

<DATE start="69917" end="69921" id="728300_869" >2003</DATE>

<CITATION end="71523" reporter="U. S." entry_type="standard_key" lookup_key="u.s._566_____" id1="625833" volume="566" start="71502" page_number="____" year="2012" standard_reporter="U.S." citation_global_level_id="2962.008" line="49" id="728300_874" citation_local_level_id="93" >566 U. S. ____ (2012)</CITATION>

<DATE start="71518" citation_global_level_id="2962.008" end="71522" id="728300_875" citation_local_level_id="93" >2012</DATE>

<NAME start="71567" local_name_id="50" end="71576" id="728300_877" all_names="SOTOMAYOR" >SOTOMAYOR</NAME>

<NAME start="71705" local_name_id="53" end="71726" id="728300_878" all_names="ORANGE BOOK ‘USE CODE" >Orange Book ‘Use Code</NAME>

<NAME start="72116" local_name_id="54" end="72121" id="728300_882" all_names="PRIOR" >Prior</NAME>

<NAME start="72399" local_name_id="55" end="72402" id="728300_883" all_names="SEE" >See</NAME>

<NAME start="72416" local_name_id="12" end="72424" id="728300_884" all_names="CONGRESS" >Congress</NAME>

<NAME start="72513" local_name_id="56" end="72519" id="728300_885" all_names="ABSENT" >Absent</NAME>

<NAME start="72541" local_name_id="8" end="72544" id="728300_886" all_names="FDA" >FDA</NAME>

<NAME start="72610" local_name_id="12" end="72618" id="728300_887" all_names="CONGRESS" >Congress</NAME>

<NAME start="72680" local_name_id="55" end="72683" id="728300_888" all_names="SEE" >See</NAME>

<NAME start="72695" local_name_id="57" end="72699" id="728300_889" all_names="CONG" >Cong</NAME>

<DATE start="72713" end="72717" id="728300_879" >2002</DATE>

<DATE start="72874" end="72887" id="728300_880" >July 18, 2002</DATE>

<DATE start="73009" end="73022" id="728300_881" >Apr. 13, 2012</DATE>

<RELATION theme="728300_7" party1="728300_8" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,        ET AL." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,        ET AL. v. NOVO NORDISK A/S ET AL" gram_type="infix" relation_type="asymmetric" id="728300_15" ></RELATION>

<RELATION party2="728300_9" theme="728300_7" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,        ET AL. v. NOVO NORDISK A/S ET AL" party2_string="NOVO NORDISK A/S ET AL" gram_type="infix" relation_type="asymmetric" id="728300_16" ></RELATION>

<RELATION at_date_string="April 17, 2012" theme="728300_12" at_date="728300_11" theme_string="The Food" gram_type="pre_nom" relation_type="asymmetric" id="728300_17" ></RELATION>

<RELATION theme="728300_18" party1="728300_19" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                     NOVO NORDISK A/S" gram_type="infix" relation_type="asymmetric" id="728300_27" ></RELATION>

<RELATION party2="728300_20" theme="728300_18" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                     NOVO NORDISK A/S" party2_string="NOVO NORDISK A/S" gram_type="infix" relation_type="asymmetric" id="728300_28" ></RELATION>

<RELATION at_date_string="2012" theme="728300_55" at_date="728300_71" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_96" ></RELATION>

<RELATION standard_case_string="559  U. S. ___" X_vs_Y_string="Johnson v. United States" standard_case="728300_56" X_vs_Y="728300_59" gram_type="apposition" relation_type="equivalence" id="728300_99" ></RELATION>

<RELATION theme="728300_59" party1="728300_63" party1_string="Johnson" theme_string="Johnson v. United States" gram_type="infix" relation_type="asymmetric" id="728300_97" ></RELATION>

<RELATION party2="728300_64" theme="728300_59" theme_string="Johnson v. United States" party2_string="United States" gram_type="infix" relation_type="asymmetric" id="728300_98" ></RELATION>

<RELATION standard_case_string="496 U.S. 661, 665" X_vs_Y_string="Eli Lilly &amp; Co. v. Medtronic, Inc" standard_case="728300_57" X_vs_Y="728300_60" gram_type="apposition" relation_type="equivalence" id="728300_102" ></RELATION>

<RELATION theme="728300_60" party1="728300_65" party1_string="Eli Lilly &amp; Co." theme_string="Eli Lilly &amp; Co. v. Medtronic, Inc" gram_type="infix" relation_type="asymmetric" id="728300_100" ></RELATION>

<RELATION party2="728300_66" theme="728300_60" theme_string="Eli Lilly &amp; Co. v. Medtronic, Inc" party2_string="Medtronic, Inc" gram_type="infix" relation_type="asymmetric" id="728300_101" ></RELATION>

<RELATION standard_case_string="502 U.S. 129, 135" X_vs_Y_string="Ardestani v. INS" standard_case="728300_58" X_vs_Y="728300_61" gram_type="apposition" relation_type="equivalence" id="728300_105" ></RELATION>

<RELATION theme="728300_61" party1="728300_67" party1_string="Ardestani" theme_string="Ardestani v. INS" gram_type="infix" relation_type="asymmetric" id="728300_103" ></RELATION>

<RELATION party2="728300_68" theme="728300_61" theme_string="Ardestani v. INS" party2_string="INS" gram_type="infix" relation_type="asymmetric" id="728300_104" ></RELATION>

<RELATION theme="728300_62" party1="728300_69" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                     NOVO NORDISK A/S" gram_type="infix" relation_type="asymmetric" id="728300_106" ></RELATION>

<RELATION party2="728300_70" theme="728300_62" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                     NOVO NORDISK A/S" party2_string="NOVO NORDISK A/S" gram_type="infix" relation_type="asymmetric" id="728300_107" ></RELATION>

<RELATION standard_case_string="268 F.3d 1323" X_vs_Y_string="Mylan Pharmaceuticals, Inc. v. Thompson" standard_case="728300_108" X_vs_Y="728300_111" gram_type="apposition" relation_type="equivalence" id="728300_122" ></RELATION>

<RELATION theme="728300_111" party1="728300_112" party1_string="Mylan Pharmaceuticals, Inc." theme_string="Mylan Pharmaceuticals, Inc. v. Thompson" gram_type="infix" relation_type="asymmetric" id="728300_120" ></RELATION>

<RELATION party2="728300_113" theme="728300_111" theme_string="Mylan Pharmaceuticals, Inc. v. Thompson" party2_string="Thompson" gram_type="infix" relation_type="asymmetric" id="728300_121" ></RELATION>

<RELATION at_date_string="2012" theme="728300_109" at_date="728300_114" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_123" ></RELATION>

<RELATION at_date_string="2012" theme="728300_137" at_date="728300_146" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_159" ></RELATION>

<RELATION theme="728300_139" includes_docket_string="10–844" includes_docket="728300_138" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL" gram_type="pre_nom" relation_type="asymmetric" id="728300_160" ></RELATION>

<RELATION theme="728300_139" party1="728300_141" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL.," theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL" gram_type="infix" relation_type="asymmetric" id="728300_161" ></RELATION>

<RELATION party2="728300_142" theme="728300_139" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL" party2_string="NOVO NORDISK A/S ET AL" gram_type="infix" relation_type="asymmetric" id="728300_162" ></RELATION>

<RELATION theme="728300_140" party1="728300_144" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_163" ></RELATION>

<RELATION party2="728300_145" theme="728300_140" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court" party2_string="NOVO NORDISK A/S                    Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_164" ></RELATION>

<RELATION standard_case_string="496 U.S. 661, 676 (1990)" X_vs_Y_string="Eli Lilly &amp; Co. v. Medtronic, Inc" standard_case="728300_331" X_vs_Y="728300_346" gram_type="apposition" relation_type="equivalence" id="728300_393" ></RELATION>

<RELATION theme="728300_346" party1="728300_353" party1_string="Eli Lilly &amp; Co." theme_string="Eli Lilly &amp; Co. v. Medtronic, Inc" gram_type="infix" relation_type="asymmetric" id="728300_391" ></RELATION>

<RELATION party2="728300_354" theme="728300_346" theme_string="Eli Lilly &amp; Co. v. Medtronic, Inc" party2_string="Medtronic, Inc" gram_type="infix" relation_type="asymmetric" id="728300_392" ></RELATION>

<RELATION at_date_string="1990" theme="728300_331" at_date="728300_368" theme_string="496 U.S. 661, 676 (1990)" gram_type="infix" relation_type="asymmetric" id="728300_394" ></RELATION>

<RELATION at_date_string="2012" theme="728300_332" at_date="728300_369" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_395" ></RELATION>

<RELATION theme="728300_347" party1="728300_355" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                     Opinion of the Court    See 21 U. S. C" gram_type="infix" relation_type="asymmetric" id="728300_396" ></RELATION>

<RELATION party2="728300_356" theme="728300_347" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                     Opinion of the Court    See 21 U. S. C" party2_string="NOVO NORDISK A/S                     Opinion of the Court    See 21 U. S. C" gram_type="infix" relation_type="asymmetric" id="728300_397" ></RELATION>

<RELATION at_date_string="2012" theme="728300_333" at_date="728300_372" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_398" ></RELATION>

<RELATION standard_case_string="347 F.3d 1335, 1349 (CA Fed. 2003)" X_vs_Y_string="Apotex, Inc. v. Thompson" standard_case="728300_334" X_vs_Y="728300_348" gram_type="apposition" relation_type="equivalence" id="728300_401" ></RELATION>

<RELATION theme="728300_348" party1="728300_357" party1_string="Apotex, Inc." theme_string="Apotex, Inc. v. Thompson" gram_type="infix" relation_type="asymmetric" id="728300_399" ></RELATION>

<RELATION party2="728300_358" theme="728300_348" theme_string="Apotex, Inc. v. Thompson" party2_string="Thompson" gram_type="infix" relation_type="asymmetric" id="728300_400" ></RELATION>

<RELATION at_date_string="2003" theme="728300_334" at_date="728300_374" theme_string="347 F.3d 1335, 1349 (CA Fed. 2003)" gram_type="infix" relation_type="asymmetric" id="728300_402" ></RELATION>

<RELATION theme="728300_349" party1="728300_359" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                  Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_403" ></RELATION>

<RELATION party2="728300_360" theme="728300_349" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                  Opinion of the Court" party2_string="NOVO NORDISK A/S                  Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_404" ></RELATION>

<RELATION standard_case_string="268 F.3d 1323 (CA Fed. 2001)" X_vs_Y_string="FTC, Mylan Pharmaceuticals, Inc. v. Thompson" standard_case="728300_336" X_vs_Y="728300_350" gram_type="apposition" relation_type="equivalence" id="728300_407" ></RELATION>

<RELATION theme="728300_350" party1="728300_361" party1_string="FTC, Mylan Pharmaceuticals, Inc." theme_string="FTC, Mylan Pharmaceuticals, Inc. v. Thompson" gram_type="infix" relation_type="asymmetric" id="728300_405" ></RELATION>

<RELATION party2="728300_362" theme="728300_350" theme_string="FTC, Mylan Pharmaceuticals, Inc. v. Thompson" party2_string="Thompson" gram_type="infix" relation_type="asymmetric" id="728300_406" ></RELATION>

<RELATION at_date_string="2001" theme="728300_336" at_date="728300_377" theme_string="268 F.3d 1323 (CA Fed. 2001)" gram_type="infix" relation_type="asymmetric" id="728300_408" ></RELATION>

<RELATION at_date_string="2012" theme="728300_337" at_date="728300_379" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_409" ></RELATION>

<RELATION at_date_string="2010" theme="728300_338" at_date="728300_383" theme_string="601 F.3d 1359, 1362 (CA Fed. 2010)" gram_type="infix" relation_type="asymmetric" id="728300_410" ></RELATION>

<RELATION theme="728300_351" party1="728300_363" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                   Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_411" ></RELATION>

<RELATION party2="728300_364" theme="728300_351" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                   Opinion of the Court" party2_string="NOVO NORDISK A/S                   Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_412" ></RELATION>

<RELATION at_date_string="2012" theme="728300_342" at_date="728300_386" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_413" ></RELATION>

<RELATION theme="728300_352" party1="728300_365" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                      NOVO NORDISK A/S                      Opinion of the Court  1366–1367. Judge Dyk" gram_type="infix" relation_type="asymmetric" id="728300_414" ></RELATION>

<RELATION party2="728300_366" theme="728300_352" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                      NOVO NORDISK A/S                      Opinion of the Court  1366–1367. Judge Dyk" party2_string="NOVO NORDISK A/S                      Opinion of the Court  1366–1367. Judge Dyk" gram_type="infix" relation_type="asymmetric" id="728300_415" ></RELATION>

<RELATION at_date_string="2011" theme="728300_345" at_date="728300_387" theme_string="564 U. S. ___ (2011)" gram_type="infix" relation_type="asymmetric" id="728300_416" ></RELATION>

<RELATION theme="728300_420" party1="728300_422" party1_string="United States" theme_string="United States v. Ron Pair Enterprises" gram_type="infix" relation_type="asymmetric" id="728300_429" ></RELATION>

<RELATION party2="728300_423" theme="728300_420" theme_string="United States v. Ron Pair Enterprises" party2_string="Ron Pair Enterprises" gram_type="infix" relation_type="asymmetric" id="728300_430" ></RELATION>

<RELATION at_date_string="1989" theme="728300_417" at_date="728300_426" theme_string="489 U.S. 235, 241 (1989)" gram_type="infix" relation_type="asymmetric" id="728300_431" ></RELATION>

<RELATION standard_case_string="519 U.S. 337, 341 (1997)" X_vs_Y_string="Robinson v. Shell Oil Co" standard_case="728300_418" X_vs_Y="728300_421" gram_type="apposition" relation_type="equivalence" id="728300_434" ></RELATION>

<RELATION theme="728300_421" party1="728300_424" party1_string="Robinson" theme_string="Robinson v. Shell Oil Co" gram_type="infix" relation_type="asymmetric" id="728300_432" ></RELATION>

<RELATION party2="728300_425" theme="728300_421" theme_string="Robinson v. Shell Oil Co" party2_string="Shell Oil Co" gram_type="infix" relation_type="asymmetric" id="728300_433" ></RELATION>

<RELATION at_date_string="1997" theme="728300_418" at_date="728300_427" theme_string="519 U.S. 337, 341 (1997)" gram_type="infix" relation_type="asymmetric" id="728300_435" ></RELATION>

<RELATION at_date_string="2011" theme="728300_419" at_date="728300_428" theme_string="775 F. Supp. 2d 985 (ED Mich. 2011)" gram_type="infix" relation_type="asymmetric" id="728300_436" ></RELATION>

<RELATION at_date_string="2012" theme="728300_615" at_date="728300_660" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_676" ></RELATION>

<RELATION standard_case_string="564 U. S. ___" X_vs_Y_string="Stern v. Marshall" standard_case="728300_616" X_vs_Y="728300_630" gram_type="apposition" relation_type="equivalence" id="728300_679" ></RELATION>

<RELATION theme="728300_630" party1="728300_640" party1_string="Stern" theme_string="Stern v. Marshall" gram_type="infix" relation_type="asymmetric" id="728300_677" ></RELATION>

<RELATION party2="728300_641" theme="728300_630" theme_string="Stern v. Marshall" party2_string="Marshall" gram_type="infix" relation_type="asymmetric" id="728300_678" ></RELATION>

<RELATION theme="728300_631" party1="728300_642" party1_string="U. S. C. §1338(a).  12    CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="U. S. C. §1338(a).  12    CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                     Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_680" ></RELATION>

<RELATION party2="728300_643" theme="728300_631" theme_string="U. S. C. §1338(a).  12    CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                     Opinion of the Court" party2_string="NOVO NORDISK A/S                     Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_681" ></RELATION>

<RELATION standard_case_string="559 U. S. ___" X_vs_Y_string="Johnson v. United States" standard_case="728300_617" X_vs_Y="728300_632" gram_type="apposition" relation_type="equivalence" id="728300_684" ></RELATION>

<RELATION theme="728300_632" party1="728300_644" party1_string="Johnson" theme_string="Johnson v. United States" gram_type="infix" relation_type="asymmetric" id="728300_682" ></RELATION>

<RELATION party2="728300_645" theme="728300_632" theme_string="Johnson v. United States" party2_string="United States" gram_type="infix" relation_type="asymmetric" id="728300_683" ></RELATION>

<RELATION standard_case_string="562 U. S. ___" X_vs_Y_string="FCC v. AT&amp;T Inc" standard_case="728300_618" X_vs_Y="728300_633" gram_type="apposition" relation_type="equivalence" id="728300_687" ></RELATION>

<RELATION theme="728300_633" party1="728300_646" party1_string="FCC" theme_string="FCC v. AT&amp;T Inc" gram_type="infix" relation_type="asymmetric" id="728300_685" ></RELATION>

<RELATION party2="728300_647" theme="728300_633" theme_string="FCC v. AT&amp;T Inc" party2_string="AT&amp;T Inc" gram_type="infix" relation_type="asymmetric" id="728300_686" ></RELATION>

<RELATION at_date_string="2012" theme="728300_619" at_date="728300_665" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_688" ></RELATION>

<RELATION theme="728300_634" party1="728300_648" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_689" ></RELATION>

<RELATION party2="728300_649" theme="728300_634" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court" party2_string="NOVO NORDISK A/S                    Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_690" ></RELATION>

<RELATION at_date_string="2012" theme="728300_621" at_date="728300_666" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_691" ></RELATION>

<RELATION theme="728300_635" party1="728300_650" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                   Opinion of the Court     The" gram_type="infix" relation_type="asymmetric" id="728300_692" ></RELATION>

<RELATION party2="728300_651" theme="728300_635" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                   NOVO NORDISK A/S                   Opinion of the Court     The" party2_string="NOVO NORDISK A/S                   Opinion of the Court     The" gram_type="infix" relation_type="asymmetric" id="728300_693" ></RELATION>

<RELATION at_date_string="2012" theme="728300_623" at_date="728300_667" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_694" ></RELATION>

<RELATION standard_case_string="496 U. S., at 667" X_vs_Y_string="Likewise, in Ardestani v. INS" standard_case="728300_624" X_vs_Y="728300_636" gram_type="pre_nom" relation_type="equivalence" id="728300_695" ></RELATION>

<RELATION standard_case_string="502 U.S. 129, 135 (1991)" X_vs_Y_string="Likewise, in Ardestani v. INS" standard_case="728300_625" X_vs_Y="728300_636" gram_type="apposition" relation_type="equivalence" id="728300_698" ></RELATION>

<RELATION theme="728300_636" party1="728300_652" party1_string="Likewise, in Ardestani" theme_string="Likewise, in Ardestani v. INS" gram_type="infix" relation_type="asymmetric" id="728300_696" ></RELATION>

<RELATION party2="728300_653" theme="728300_636" theme_string="Likewise, in Ardestani v. INS" party2_string="INS" gram_type="infix" relation_type="asymmetric" id="728300_697" ></RELATION>

<RELATION at_date_string="1991" theme="728300_625" at_date="728300_668" theme_string="502 U.S. 129, 135 (1991)" gram_type="infix" relation_type="asymmetric" id="728300_699" ></RELATION>

<RELATION theme="728300_637" party1="728300_654" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                  Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_700" ></RELATION>

<RELATION party2="728300_655" theme="728300_637" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                  Opinion of the Court" party2_string="NOVO NORDISK A/S                  Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_701" ></RELATION>

<RELATION at_date_string="2012" theme="728300_628" at_date="728300_669" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_702" ></RELATION>

<RELATION standard_case_string="534 U.S. 19, 31 (2001)" X_vs_Y_string="TRW Inc. v. Andrews" standard_case="728300_629" X_vs_Y="728300_638" gram_type="apposition" relation_type="equivalence" id="728300_705" ></RELATION>

<RELATION theme="728300_638" party1="728300_656" party1_string="TRW Inc." theme_string="TRW Inc. v. Andrews" gram_type="infix" relation_type="asymmetric" id="728300_703" ></RELATION>

<RELATION party2="728300_657" theme="728300_638" theme_string="TRW Inc. v. Andrews" party2_string="Andrews" gram_type="infix" relation_type="asymmetric" id="728300_704" ></RELATION>

<RELATION at_date_string="2001" theme="728300_629" at_date="728300_670" theme_string="534 U.S. 19, 31 (2001)" gram_type="infix" relation_type="asymmetric" id="728300_706" ></RELATION>

<RELATION theme="728300_639" party1="728300_658" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                  Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_707" ></RELATION>

<RELATION party2="728300_659" theme="728300_639" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                  Opinion of the Court" party2_string="NOVO NORDISK A/S                  Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_708" ></RELATION>

<RELATION standard_case_string="507 U.S. 197, 203" X_vs_Y_string="Smith v. United States" standard_case="728300_742" X_vs_Y="728300_748" gram_type="apposition" relation_type="equivalence" id="728300_775" ></RELATION>

<RELATION theme="728300_748" party1="728300_752" party1_string="Smith" theme_string="Smith v. United States" gram_type="infix" relation_type="asymmetric" id="728300_773" ></RELATION>

<RELATION party2="728300_753" theme="728300_748" theme_string="Smith v. United States" party2_string="United States" gram_type="infix" relation_type="asymmetric" id="728300_774" ></RELATION>

<RELATION at_date_string="2012" theme="728300_743" at_date="728300_762" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_776" ></RELATION>

<RELATION standard_case_string="531 U.S. 159, 170 (2001)" X_vs_Y_string="Solid Waste Agency of Northern Cook Cty. v. Army Corps of Engineers" standard_case="728300_744" X_vs_Y="728300_749" gram_type="apposition" relation_type="equivalence" id="728300_779" ></RELATION>

<RELATION theme="728300_749" party1="728300_754" party1_string="Solid Waste Agency of Northern Cook Cty." theme_string="Solid Waste Agency of Northern Cook Cty. v. Army Corps of Engineers" gram_type="infix" relation_type="asymmetric" id="728300_777" ></RELATION>

<RELATION party2="728300_755" theme="728300_749" theme_string="Solid Waste Agency of Northern Cook Cty. v. Army Corps of Engineers" party2_string="Army Corps of Engineers" gram_type="infix" relation_type="asymmetric" id="728300_778" ></RELATION>

<RELATION at_date_string="2001" theme="728300_744" at_date="728300_763" theme_string="531 U.S. 159, 170 (2001)" gram_type="infix" relation_type="asymmetric" id="728300_780" ></RELATION>

<RELATION theme="728300_750" party1="728300_756" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_781" ></RELATION>

<RELATION party2="728300_757" theme="728300_750" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court" party2_string="NOVO NORDISK A/S                    Opinion of the Court" gram_type="infix" relation_type="asymmetric" id="728300_782" ></RELATION>

<RELATION at_date_string="2012" theme="728300_747" at_date="728300_766" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_783" ></RELATION>

<RELATION theme="728300_751" party1="728300_758" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court    Tr. of Oral Arg" gram_type="infix" relation_type="asymmetric" id="728300_784" ></RELATION>

<RELATION party2="728300_759" theme="728300_751" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                  NOVO NORDISK A/S                    Opinion of the Court    Tr. of Oral Arg" party2_string="NOVO NORDISK A/S                    Opinion of the Court    Tr. of Oral Arg" gram_type="infix" relation_type="asymmetric" id="728300_785" ></RELATION>

<RELATION at_date_string="2012" theme="728300_792" at_date="728300_793" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_796" ></RELATION>

<RELATION theme="728300_838" includes_docket_string="10–844" includes_docket="728300_837" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL" gram_type="pre_nom" relation_type="asymmetric" id="728300_856" ></RELATION>

<RELATION theme="728300_838" party1="728300_842" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL.," theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL" gram_type="infix" relation_type="asymmetric" id="728300_857" ></RELATION>

<RELATION party2="728300_843" theme="728300_838" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD.,  ET AL., PETITIONERS v. NOVO NORDISK A/S ET AL" party2_string="NOVO NORDISK A/S ET AL" gram_type="infix" relation_type="asymmetric" id="728300_858" ></RELATION>

<RELATION standard_case_string="496 U.S. 661, 676 (1990)" X_vs_Y_string="Eli Lilly &amp; Co. v. Medtronic, Inc" standard_case="728300_835" X_vs_Y="728300_839" gram_type="apposition" relation_type="equivalence" id="728300_861" ></RELATION>

<RELATION theme="728300_839" party1="728300_845" party1_string="Eli Lilly &amp; Co." theme_string="Eli Lilly &amp; Co. v. Medtronic, Inc" gram_type="infix" relation_type="asymmetric" id="728300_859" ></RELATION>

<RELATION party2="728300_846" theme="728300_839" theme_string="Eli Lilly &amp; Co. v. Medtronic, Inc" party2_string="Medtronic, Inc" gram_type="infix" relation_type="asymmetric" id="728300_860" ></RELATION>

<RELATION at_date_string="1990" theme="728300_835" at_date="728300_852" theme_string="496 U.S. 661, 676 (1990)" gram_type="infix" relation_type="asymmetric" id="728300_862" ></RELATION>

<RELATION theme="728300_840" party1="728300_847" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                    NOVO NORDISK A/S                   SOTOMAYOR, J" gram_type="infix" relation_type="asymmetric" id="728300_863" ></RELATION>

<RELATION party2="728300_848" theme="728300_840" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                    NOVO NORDISK A/S                   SOTOMAYOR, J" party2_string="NOVO NORDISK A/S                   SOTOMAYOR, J" gram_type="infix" relation_type="asymmetric" id="728300_864" ></RELATION>

<RELATION at_date_string="2012" theme="728300_836" at_date="728300_853" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_865" ></RELATION>

<RELATION theme="728300_841" party1="728300_849" party1_string="CARACO PHARMACEUTICAL LABORATORIES, LTD." theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                    NOVO NORDISK A/S" gram_type="infix" relation_type="asymmetric" id="728300_866" ></RELATION>

<RELATION party2="728300_850" theme="728300_841" theme_string="CARACO PHARMACEUTICAL LABORATORIES, LTD. v.                    NOVO NORDISK A/S" party2_string="NOVO NORDISK A/S" gram_type="infix" relation_type="asymmetric" id="728300_867" ></RELATION>

<RELATION at_date_string="2012" theme="728300_874" at_date="728300_875" theme_string="566 U. S. ____ (2012)" gram_type="infix" relation_type="asymmetric" id="728300_876" ></RELATION>

